Albert Lowe's Stock Ratings

Craig-Hallum Analyst

Albert Lowe is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

15.1%

Smart Score

56.4%

Overall Average Return Percentile

69th

Number of Ratings

10
Buy NowGet Alert
12/04/2025PVLABuy Now
Palvella Therapeutics
$93.7086.77% → $175Initiates → BuyGet Alert
06/17/2025NGNEBuy Now
Neurogene
$20.98138.35% → $50Initiates → BuyGet Alert
06/05/2025ATOSBuy Now
Atossa Therapeutics
$0.73448.77% → $4Initiates → BuyGet Alert
04/11/2025IRDBuy Now
Opus Genetics
$2.15179.07% → $6Initiates → BuyGet Alert
03/21/2025SKYEBuy Now
Skye Bioscience
$1.111155.61%$18 → $14MaintainsBuyGet Alert
10/09/2024SABSBuy Now
SAB Biotherapeutics
$3.90182.05% → $11Initiates → BuyGet Alert
09/06/2024CRDFBuy Now
Cardiff Oncology
$2.41231.95% → $8Initiates → BuyGet Alert
08/20/2024LCTXBuy Now
Lineage Cell Therapeutics
$1.73131.21% → $4Initiates → BuyGet Alert
07/09/2024SKYEBuy Now
Skye Bioscience
$1.111514.35% → $18Initiates → BuyGet Alert
05/13/2024PMVPBuy Now
PMV Pharma
$1.17411.42% → $6Initiates → BuyGet Alert